The evolution of adjunctive antiplatelet therapy in non urgent PCI
An EBAC Accredited Educational Programme supported with an unrestricted educational grant from AstraZeneca.
Session details
- Chairpersons: Hugo KATUS, Patrick W. SERRUYS
- Speakers: Patrick W. SERRUYS, Andreas BAUMBACH, Ph. Gabriel STEG, Marco VALGIMIGLI, Hugo KATUS
- Objectives:
To learn about evolving evidence in adjunctive antiplatelet therapy
To appreciate the importance of discharge treatment plans
To understand the issues surrounding short versus long-term antiplatelet therapy
This programme was EBAC accredited during the EuroPCR Congress 2014, however no CME credits will be provided for viewing this web-cast.
-
Hugo Katus
Prof. Katus is Clinical Director of the Department of Cardiology, Angiology and Pneumology, as well as Managing Director of the Medical Clinic, Heidelberg.
-
Patrick W. Serruys
Patrick W. Serruys, is Professor of Interventional Cardiology at the Interuniversity Cardiological Institute of The Netherlands, and the Erasmus University.